These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25661365)

  • 1. The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients.
    Zhang CY; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
    Biomed Pharmacother; 2015 Feb; 69():242-8. PubMed ID: 25661365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.
    Kirshberg S; Izhar U; Amir G; Demma J; Vernea F; Beider K; Shlomai Z; Wald H; Zamir G; Shapira OM; Peled A; Wald O
    PLoS One; 2011; 6(9):e24856. PubMed ID: 21949768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of CD4⁺FOXP3⁺ T cells by CCL20/CCR6 axis in early unexplained recurrent miscarriage patients.
    Zhang XX; Kang XM; Zhao AM
    Genet Mol Res; 2015 Aug; 14(3):9145-54. PubMed ID: 26345847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma.
    Liu JY; Li F; Wang LP; Chen XF; Wang D; Cao L; Ping Y; Zhao S; Li B; Thorne SH; Zhang B; Kalinski P; Zhang Y
    Br J Cancer; 2015 Sep; 113(5):747-55. PubMed ID: 26284335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.
    Chen KJ; Lin SZ; Zhou L; Xie HY; Zhou WH; Taki-Eldin A; Zheng SS
    PLoS One; 2011; 6(9):e24671. PubMed ID: 21935436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR6/CCL20 chemokine expression profile in distinct colorectal malignancies.
    Frick VO; Rubie C; Kölsch K; Wagner M; Ghadjar P; Graeber S; Glanemann M
    Scand J Immunol; 2013 Sep; 78(3):298-305. PubMed ID: 23790181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and clinical significance of CCR6, CCR7 and CD4(+)CD25(+) Foxp3(+) regulatory T cells in laryngeal squamous cell carcinoma and neck lymphatic metastasis].
    Chen B; Lu LM; Tao L; Zhou L; Li SM; Zhu L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Sep; 45(9):759-64. PubMed ID: 21092675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enrichment of Human CCR6
    Lee JJ; Kao KC; Chiu YL; Jung CJ; Liu CJ; Cheng SJ; Chang YL; Ko JY; Chia JS
    J Immunol; 2017 Jul; 199(2):467-476. PubMed ID: 28600287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ expression of the CCL20-CCR6 axis in lymphocyte-rich gastric cancer and its potential role in the formation of lymphoid stroma.
    Ohtani H; Nakayama T; Yoshie O
    Pathol Int; 2011 Nov; 61(11):645-51. PubMed ID: 22029675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of CCR6 and CCR7 in laryngeal squamous cell carcinoma].
    Chen B; Lu L; Tao L; Zhou L; Li S; Zhu L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Nov; 24(21):975-9. PubMed ID: 21261017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High CCR6/CCR7 expression and Foxp3+ Treg cell number are positively related to the progression of laryngeal squamous cell carcinoma.
    Chen B; Zhang D; Zhou J; Li Q; Zhou L; Li SM; Zhu L; Chou KY; Zhou L; Tao L; Lu LM
    Oncol Rep; 2013 Sep; 30(3):1380-90. PubMed ID: 23835793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy.
    Rutihinda C; Haroun R; Saidi NE; Ordoñez JP; Naasri S; Lévesque D; Boisvert FM; Fortier PH; Belzile M; Fradet L; Hubert-Tremblay V; Turgeon GA; Wang CS; Delage P; Rousseau É; Paquette B; Oweida AJ
    Cancer Immunol Immunother; 2023 May; 72(5):1089-1102. PubMed ID: 36326893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panel of miR-150 and linc00673, regulators of CCR6/CCL20 may serve as non-invasive diagnostic marker of non-small cell lung cancer.
    Baran K; Kordiak J; Jabłoński S; Brzeziańska-Lasota E
    Sci Rep; 2023 Jun; 13(1):9642. PubMed ID: 37316552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production.
    Zeng W; Chang H; Ma M; Li Y
    Exp Mol Pathol; 2014 Aug; 97(1):184-90. PubMed ID: 24984269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-derived CCL20 affects B16 melanoma growth in mice.
    Martin-Garcia D; Silva-Vilches C; Will R; Enk AH; Lonsdorf AS
    J Dermatol Sci; 2020 Jan; 97(1):57-65. PubMed ID: 31883833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco smoke induces production of chemokine CCL20 to promote lung cancer.
    Wang GZ; Cheng X; Li XC; Liu YQ; Wang XQ; Shi X; Wang ZY; Guo YQ; Wen ZS; Huang YC; Zhou GB
    Cancer Lett; 2015 Jul; 363(1):60-70. PubMed ID: 25864589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients.
    Petersen RP; Campa MJ; Sperlazza J; Conlon D; Joshi MB; Harpole DH; Patz EF
    Cancer; 2006 Dec; 107(12):2866-72. PubMed ID: 17099880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway.
    Lu E; Su J; Zhou Y; Zhang C; Wang Y
    Biomed Pharmacother; 2017 Jan; 85():486-492. PubMed ID: 27916417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice.
    Liu J; Zhang N; Li Q; Zhang W; Ke F; Leng Q; Wang H; Chen J; Wang H
    PLoS One; 2011 Apr; 6(4):e19495. PubMed ID: 21559338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling.
    Wei W; Zhao X; Zhu J; Zhang L; Chen Y; Zhang B; Li Y; Wang M; Zhang Z; Wang C
    Oncol Rep; 2019 Nov; 42(5):1946-1956. PubMed ID: 31545478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.